Bioabsorbable implantable endoprosthesis with reservoir

United States Patent [w]

Stinson

US005980564A [ii] Patent Number: [45] Date of Patent:

5,980,564 Nov. 9,1999

Studies on a new radiopaguepolymeric biomaterial, A. Benzina, M.A.B. Kruft, F. Bar, F.H. van deer Veen, C.W. Bastiaansen, V. Heijnen, C. Reutelingsperger, and L.H. Koole, Biomaterials 1994, vol. 15 No. 14, pp. 1122-1128. Deformation Characteristics of a Bioabsorbable Intravascular Stent, C. Mauli Agrawal, Ph.D., PE. and Howard G. Clark, Ph.D., Investigative Radiology, Dec. 1992, vol. 27, pp. 1020-1024.

Studies on radio-opaque polymeric biomaterials with potential applications to endovascular protheses, M. Kruft, A. Benzina, R. Blezer, and L. Koole, Biomaterials 1996, vol. 17, No. 18, pp. 1803-1812.

Advertisement for radiopaque polymers for medical device maunfacturing, New England Urethane, Inc. Gianturco-Roubin Flex-Stent GRII, M-D-D-I Report— "The Gray Sheet", Mar. 4, 1996.

Seventh Complex Coronary Angioplasty Course, May 1996, p. 257.

Synthetic Bioabsorbable Polymers, Thomas H. Barrows, Ph.D., High Performance Biomaterials, Szycher ed., pp. 243-257.

Wound Closure Biomaterials and Devices, C.C. Chu, J.A. von Fraunhofer, amd H.P Greisler, CTC Press, Boca Raton, FL, 1997 pp. 131-235.

In Vitro Degradation of Polylactides Depending on Different Processes, M. Dauner, E. Muller, B. Wagner, and H. Planck, Degradation Phenomena on Polymeric Biomaterials, H. Planck, M. Dauner, M. Renardy (eds), Springer-Verlag, Berlin, 1992, pp. 107-122.

(List continued on next page.)

Primary Examiner—Mickey Yu

Assistant Examiner—Dinh X. Nguyen

Attorney, Agent, or Firm—Larkin, Hoffman, Daly &

Lindgren, Ltd.

U.S. PATENT DOCUMENTS

4,475,972 10/1984 Wong 156/167

4,681,110 7/1987 Wiktor 128/343

4,693,234 9/1987 Hoffman et al 128/1

4,722,344 2/1988 Cambron et al 128/658

4,738,740 4/1988 Pinchuk et al 156/167

4,787,391 11/1988 Elefteriades 128/654

4,968,317 11/1990 Tormalaet al 606/77

5,015,183 5/1991 Fenick 433/76

5,024,232 6/1991 Smid et al 128/654

5,026,377 6/1991 Burton et al 606/108

5,047,050 9/1991 Arpesani 623/1

5,059,211 10/1991 Stack et al 606/198

5,061,275 10/1991 Wallsten et al 623/1

5,085,629 2/1992 Goldberg et al 604/8

5,116,360 5/1992 Pinchuk et al 623/1

5,133,660 7/1992 Fenick 433/76

5,133,742 7/1992 Pinchuk 623/1

5,160,341 11/1992 Brenneman et al 606/198

5,163,951 11/1992 Pinchuk et al 623/1

5,177,170 1/1993 Sarpeshkar et al 528/76

5,201,757 4/1993 Heyn et al 606/198

5,203,777 4/1993 Lee 604/280

5,229,431 7/1993 Pinchuk 521/159

5,256,158 10/1993 Tolkoff et al 604/280

5,306,286 4/1994 Stack et al 606/198

5,320,602 6/1994 Karpiel 604/54

5,346,981 9/1994 Sarpeshkar et al 528/85

5,354,257 10/1994 Roubin et al 600/7

5,366,504 11/1994 Andersen et al 623/11

5,405,402 4/1995 Dye et al 623/22

5,415,546 5/1995 Cox, Sr. 433/213

5,419,760 5/1995 Narciso 604/8

5,423,849 6/1995 Engelson et al 606/191

5,429,617 7/1995 Hammersmark et al 604/264

5,433,727 7/1995 Sideris 606/213

5,441,517 8/1995 Kensey et al 606/213

5,464,450 11/1995 Buscemi et al 623/6

5,464,650 11/1995 Berg et al 427/2.3

5,478,352 12/1995 Fowler 606/213

5,484,444 1/1996 Braunschweiler et al 606/108

5,498,227 3/1996 Mawad 600/3

5,500,013 3/1996 Buscemi et al 623/1

5,527,337 6/1996 Stack et al 606/198

5,527,354 6/1996 Fontaine et al 623/1

5,545,208 8/1996 Wolff et al 623/1

5,551,954 9/1996 Buscemi et al 523/1

5,556,413 9/1996 Lam 606/198

5,591,172 1/1997 Bachmann et al 606/108

5,591,222 1/1997 Susawa et al 623/1

5,591,224 1/1997 Schwartz et al 623/1

5,591,226 1/1997 Trerotola etal 623/1

5,609,627 3/1997 Goicoechea et al 623/1

5,624,411 4/1997 Tuch 604/265

5,628,755 5/1997 Heller et al 606/108

5.628.787 5/1997 Mayer 623/1

5.628.788 5/1997 Pinchuk 623/1

5,630,840 5/1997 Mayer 623/1

5,645,559 7/1997 Hachtman et al 606/198

5,653,747 8/1997 Dereume 623/1

5,662,703 9/1997 Yurek et al 623/1

5,670,161 9/1997 Healy et al 424/426

5,674,277 10/1997 Freitag 623/1

5,674,286 10/1997 D'Alessio et al 623/11

5,676,146 10/1997 Scarborough 128/654

5,683,448 11/1997 Marcade 623/1

5,697,969 12/1997 Schmitt et al 623/1

5,700,285 12/1997 Myers et al 623/1

5,725,517 3/1998 DeBusk 604/362

5,725,567 3/1998 Wolff et al 623/1

5,725,572 3/1998 Lam et al 623/1

5,741,327 4/1998 Frantzen 623/1

5,762,625 6/1998 Igaki 604/8

5,843,158 12/1998 Lenker, et al 623/1

Bl 4,655,771 9/1996 Wallsten 623/1

Bl 4,954,126 5/1996 Wallsten 600/36

OTHER PUBLICATIONS

Long-term in vivo degradation and bone reaction to various polylactides, P. Mainil-Varlet, B. Rahn, and S. Goglewski, Biomaterials 1997, vol. 18, No. 3, pp. 257-266. Current Status of Biodegradable Stents, J.F., Tanguay, M.D., J.P Zidar, M.D., H.R. Phillips, III, M.D., and R. S. Stack, M.D., Cardiology Clinics, vol. 12, No. 4, Nov. 1994, pp. 699-713.

Perspectives on the In Vivo Responses of Biodegradable Polymers, James M. Anderson, M.D., Ph.D., CTC Press Inc., (1995) pp. 223-233, 1995.

Advances in Controlled Release Technology: Polymeric Delivery System for Drugs, Pesticides and Foods: New Methods of Drug Delivery, Robert Langer, Science vol. 249, pp. 1527-1533.

Advances in Controled Release Technology: Polymeric Delivery System s for Drugs, Pesticides and Foods: Fundamentals pf pH. and Temperature-Sensitive Polymers, Nicholas A. Peppas, pp. 32^-5.

Bioabsorbable Stent and Method of Making the Same, Assignee: Duke University.

Enhancement of the Mechanical Properties of Polylactides by solid-state extrusion, Walter Weiler and Sylwester Gogolewski, Biomaterials 17 (1996), pp. 529-535. The Physics of Radiology, H.E. Johns and J. R. Cunningham, pp. 137-142.

Bicomponent vascular grafts consisting of synthetic absorbable fibers. I. In Vitro Study, Tarng-Jenn Yu and C.C. Chu, Journal of Biomedical Materoa;s Research, vol. 27, 1329-1339 (1993).

Biomedical Applications of Synthetic Biodegradable Polymers, Editited by Jeffrey O. Hollinger, D.D.S., Ph.D., CTC Press, p. 21.

Development of a Polymer Endovascular Prothesis and Its Implantation in Porcine Arteries, William J. Van der Giessen, M.D., et al., Journal of Interventional Cardiology, vol. 5, No. 3, 1992, pp. 175-185.

Role of Polymers in improving the results of stenting in coronary arteries, Tao Peng, et al., Biomaterials 1996, vol. 17, No. 7, pp. 685-694.

Bioabsorbable, Drug-Eluting, Intracoronary Stents: Design and Future Applications, R.S. Schwartz, et al., Coronary Stents (1992), pp. 135-154.

Ten Years of Stenting: What Next?, Ulrich Sigwart, M.D., FRCP, FACC, FESC, Journal of Interventional Cardiology, vol. 10, No. 3, pp. 195-205.

Biocompatibility of solid poly (ortho ester), M. Ekholm, et al., Journal of Materials Science: Materials in Medicine 8, (1997), pp. 265-269.

The Polymer Stent, Jean-Frangois Tanguay, et al., Endoluminal Stenting, pp. 216-225.